Next Generation Blood Separation Technology Receives CE Marking

A next-generation blood separation technology that is designed to enhance sample quality, improve laboratory efficiency and reduce laboratory turnaround time has received the Conformité Européenne (CE) marking.

The tube is a single-use, plastic evacuated tube used to collect, separate, transport and process venous blood specimens to obtain high-quality plasma for in vitro diagnostic use and the tube has a revolutionary separator technology, providing a cleaner plasma sample with less cellular contamination, meaning the sample is more stable and allows a longer window to conduct testing when compared to existing blood separation tubes.

BD Barricor tubes (BD, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) are optimized to deliver a high quality plasma sample by reducing cellular content (versus plasma gel tubes), as a result of the mechanical separator remaining open throughout the centrifugation cycle. It eliminates gel artifacts which can lead to instrument downtime. These factors together with longer sample stability can significantly improve the sample and laboratory workflow.

The tube has a revolutionary separator technology, providing a cleaner plasma sample with less cellular contamination, meaning the sample is more stable and allows a longer window to conduct testing when compared to existing blood separation tubes. The Barricor tubes deliver a faster time-to-result for patients, with no clotting time required and a reduction in centrifugation time of up to seven minutes, an overall saving in turnaround time of 37 minutes is possible.

Lisa Nibauer, MBA, vice president and general manager of Global Marketing for BD Life Sciences, said, “Laboratory technicians are forced to choose between a clean sample with serum and a fast sample with plasma. BD Barricor tubes eliminate this tradeoff, providing a cleaner and faster plasma sample than current methods.”

Related Links:
Becton, Dickinson and Company